March 4, 2013
The Tokyo District Court dismissed on February 28 Takeda Pharmaceutical’s patent infringement litigation against companies that obtained listing of generic versions of its type 2 diabetes treatment Actos (pioglitazone) in June 2011 and subsequently launched these products. The company had...read more